Neurological manifestations of patients with mild-to-moderate COVID-19 attending a public hospital in Lima, Peru
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2021.03.16.21253736: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Following explanation of the study procedures and obtaining verbal consent, a face-to-face interview was performed by the physician.
IRB: Ethical Considerations: This study was approved by the Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI) COVID-19-specific ethics committee on July 13, 2020.Randomization not detected. Blinding not detected. Power Analysis Our sample of 165 patients with neurological symptoms and 34 without neurological symptoms had a power of 87% to detect differences of 30% or more of the prevalence of comorbidities or non-neurological symptoms. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sen… SciScore for 10.1101/2021.03.16.21253736: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Following explanation of the study procedures and obtaining verbal consent, a face-to-face interview was performed by the physician.
IRB: Ethical Considerations: This study was approved by the Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI) COVID-19-specific ethics committee on July 13, 2020.Randomization not detected. Blinding not detected. Power Analysis Our sample of 165 patients with neurological symptoms and 34 without neurological symptoms had a power of 87% to detect differences of 30% or more of the prevalence of comorbidities or non-neurological symptoms. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources Inclusion criteria were: age greater than 18 years and confirmed COVID-19 infection by real-time reverse transcriptase-polymerase chain reaction (rt-PCR) or by rapid antibody test (either IgM and/or IgG positive). rt-PCRsuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Our study has several limitations. First, this was a cross-sectional study that captured data from participants at the time of hospital admission and did not track their clinical status over time. Thus, we do not have information on their hospital admission course, discharge or outcomes during or after hospitalization. Given the cross-sectional nature of the study, we cannot comment on whether patients presenting with mild symptoms to a public hospital in Peru have greater risk of worse outcomes if they had a neurological symptom at disease onset. Second, the study did not assess temporal patterns of neurological symptoms, thus we do not know which symptoms may have presented first and in what sequence. Third, this was a population of patients presenting with mild respiratory symptoms to a public hospital in Lima, Peru, thus we are unable to extrapolate results to other geographic regions of Peru, such as more rural regions, or to patients with moderate-to-severe symptoms of COVID-19 in Peru. Moreover, at the time of this study, rt-PCR testing was not widely available in public hospitals in Lima, Peru, thus serological antibody testing for confirmation of COVID-19 exposure was considered the most appropriate measure for diagnosis of acute COVID-19. Because we followed the diagnostic and management guidelines of public Peruvian hospitals, patients with a positive anti-SARS-CoV-2 IgM or IgG and compatible COVID-19 symptoms were considered to have acute COVID-19. Thus, there is ...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-